BIOXYTRAN, INC

BIXT · OTC · SIC 2834: Pharmaceutical Preparations
201
SEC Filings

Business Summary

PART I . GENERAL ORGANIZATION AND BUSINESS Bioxytran, Inc. (we, us, or the Company) is a clinical stage pharmaceutical company focused on the development, manufacture and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen to tissues. Hypoxia needs to be addressed quickly, otherwise it results in necrosis, which is the death of cells comprising body tissue. Necrosis cannot be reversed. Our lead drug candidate, code named BXT-25, is an oxygen-ca...

Next Earnings

Q2 FY2026 — expected 2026-08-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBIXTdiscussed_in_filing Cybersecurity
topic_mentionBIXTdiscussed_in_filing Trusted Computing
topic_mentionBIXTdiscussed_in_filing Blockchain & Crypto
topic_mentionBIXTdiscussed_in_filing Regulation
topic_mentionBIXTdiscussed_in_filing Healthcare & Bio
topic_mentionBIXTdiscussed_in_filing Cybersecurity
topic_mentionBIXTdiscussed_in_filing Trusted Computing
topic_mentionBIXTdiscussed_in_filing Blockchain & Crypto
topic_mentionBIXTdiscussed_in_filing Regulation
topic_mentionBIXTdiscussed_in_filing Healthcare & Bio
topic_mentionBIXTdiscussed_in_filing Cybersecurity
topic_mentionBIXTdiscussed_in_filing Trusted Computing
topic_mentionBIXTdiscussed_in_filing Blockchain & Crypto
topic_mentionBIXTdiscussed_in_filing Regulation
topic_mentionBIXTdiscussed_in_filing Healthcare & Bio
topic_mentionBIXTdiscussed_in_filing Cybersecurity
topic_mentionBIXTdiscussed_in_filing Trusted Computing
topic_mentionBIXTdiscussed_in_filing Blockchain & Crypto
topic_mentionBIXTdiscussed_in_filing Regulation
topic_mentionBIXTdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-032024-12-310001641172-25-002614EDGAR52K words
2024-03-222023-12-310001493152-24-011014EDGAR—
2023-03-312022-12-310001493152-23-010104EDGAR—
2022-04-112021-12-310001539497-22-000793EDGAR—
2021-04-092020-12-310001785982-21-000076EDGAR—
2020-03-182019-12-310001213900-20-006766EDGAR—
2019-03-132018-12-310001213900-19-004006EDGAR—
2018-04-022017-12-310001213900-18-003761EDGAR—
2017-03-312016-12-310001213900-17-003123EDGAR—
2016-07-222015-12-310001213900-16-015178EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023399EDGAR24K words
2025-08-112025-06-300001493152-25-011797EDGAR—
2025-05-152025-03-310001641172-25-010822EDGAR—
2024-10-292024-09-300001493152-24-042763EDGAR—
2024-08-142024-06-300001493152-24-032356EDGAR—
2024-04-192024-03-310001493152-24-015358EDGAR—
2023-11-032023-09-300001493152-23-039202EDGAR—
2023-07-312023-06-300001493152-23-026050EDGAR—
2023-05-122023-03-310001493152-23-016483EDGAR—
2022-11-102022-09-300001493152-22-031402EDGAR—
2022-08-152022-06-300001493152-22-022572EDGAR—
2022-05-232022-03-310001539497-22-001047EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-200001493152-26-011755EDGAR1K words
2026-03-130001493152-26-010045EDGAR—
2026-03-020001493152-26-008475EDGAR—
2026-02-170001493152-26-006891EDGAR—
2026-02-110001493152-26-006081EDGAR—
2026-01-050001493152-26-000418EDGAR—
2025-12-150001493152-25-027639EDGAR—
2025-01-220001493152-25-003136EDGAR—
2025-01-130001493152-25-001891EDGAR—
2025-01-100001493152-25-001603EDGAR—

201 total filings indexed. 169 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001445815
TickerBIXT
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d3a65bf5df40fedc78a64076544047b5bd2407e4e97643143c7c3ba057241be1
parent: cffe988c6ec70e36cc9344e7a7c82cb31853ce0096918b02bfa9eb6fbc9d1c8c
content hash: 6f42fbedf7617ab011e2f53bfc8c25fad23e3c69e54d26c973c18a43f5e895cb
signed: 2026-04-13T04:43:58.890Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf